Purchases and Sales Made in Q2 2023 in Intercept Pharmaceuticals, Inc. (ICPT)
This table provides information about the institutional ownership of Intercept Pharmaceuticals, Inc. (ICPT) during Q2 2023. The information is specifically focused on institutions that hold shares of INTERCEPT PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-383K- 46.93% |
$3.51M - $7.38M
|
433K
$0
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-466K- 61.02% |
$4.27M - $8.98M
|
297K
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-466K- 61.02% |
$4.27M - $8.98M
|
297K
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-659K- 96.07% |
$6.05M - $12.7M
|
27K
$0
|